Summary We examined 26 gastric carcinomas from British patients for mutations of the APC gene using a single-strand conformation polymorphism (SSCP) and heteroduplex assay in conjunction with the protein truncation test (PTT). In addition, we performed loss of heterozygosity (LOH) analysis of the APC and MCC genes. We detected an inactivating somatic mutation in one gastric tumour. LOH of APC was observed in one of 12 informative cases (8%) and of MCC in two of 20 cases (10%). We thus find that alterations of the APC and MCC genes are infrequent in gastric cancers from the British population. Tumour-suppressor genes on other chromosomes must play a more significant role in the development of these tumours.
The development of human cancer is thought to involve an accumulation of genetic alterations. The alterations associated with colorectal cancer are well characterised and a genetic model of tumour progression has been proposed (Fearon and Vogelstein, 1990) . Inactivation of the tumoursuppressor gene, APC (adenomatous polyposis coli), is thought to be an initiating event (Powell et al., 1992) . Germline mutations of the APC gene are responsible for familial adenomatous polyposis (FAP) (Nishisho et al., 1991; Groden et al., 1991) . Allele loss of another tumoursuppressor gene, MCC (mutated in colorectal cancer), which lies in close proximity to APC on chromosome 5q22, is also frequent and mutations have been described in some colorectal tumours (Kinzler et al., 1991) .
Loss of heterozygosity (LOH) of the 5q21-22 region has been reported to be frequent in many other human malignancies including gastric (Sano et al., 1991) , oesophageal (Boynton et al., 1992) and lung cancer (D'Amico et al., 1992) . Furthermore, somatic mutations of the APC gene have been described in several tumour types such as pancreatic cancer , oral squamous-cell carcinoma (Uzawa et al., 1994) and oesophageal cancer (Powell et al., 1994) . In the stomach, APC mutations have been reported in gastric adenomas (Nakatsuru et al., 1993; Tamura et al., 1994) and in differentiated and signet-ring cell carcinomas Maesawa et al., 1995) . These studies have involved analysis of gastric tumours from Japanese patients. Gastric cancer is not as prevalent in Britain, probably due to environmental differences, which may be reflected by a different molecular pathogenesis.
We decided to examine a series of gastric carcinomas from UK patients for mutations of the APC gene and for LOH at sites within the APC and MCC genes. We used single strand conformation polymorphism (SSCP) and heteroduplex analysis to screen exons 6, 8, 11, 14 and the 5' half of exon 15 of APC, which includes a region where the majority of somatic mutations are clustered (mutation cluster region or MCR) Protein truncation test (PTT) DNA template for the in vitro transcription and translation reaction was generated from genomic DNA using primers described by Van Der Luijt et al. (1994) . The sense primer included a T7 promoter sequence for transcription initiation and Kozak consensus sequence for translation initiation at the 5' end, in frame with APC unique sequence. A 2 kb product was amplified and used directly in a TNT lysate coupled transcription/translation reaction (Promega) with incorporation of 35S-methionine to detect the translation products, which were then separated on a sodium dodecyl sulphate (SDS)-polyacrylamide gel with a gradient of 10-20%. The gels were fixed, dried and autoradiographed at room temperature.
Detection of mutations by restriction digest Some relatively common mutations in exons 6, 8 and 14 alter the recognition site of restriction enzymes (Ando et al., 1993) . The specific mutation detected together with restriction enzyme used and size of fragments expected after digestion of PCR products are given in Table I . Digestion products were analysed by electrophoresis in 2% agarose gels which were stained with ethidium bromide and photographed under UV light. (Greenwald et al., 1992) . Only patients who showed constitutional heterozygosity at a given locus were considered informative for this study.
Results

SSCP and heteroduplex analysis
We analysed over 40% of the coding region of the APC gene. A somatic variant was detected in one of 26 gastric cancers (4%) as shown in Figure la . This was an intestinal type tumour (GACA17). Subsequent sequencing revealed that we had detected a 4 bp deletion of either AGAG or GAGA in the sequence GAAAAGAGAGAGAGT at codon 1462-1465 (Figure lb) . This mutation was located within the MCR (codons 1286-1513). The deletion was predicted to lead to truncation of the protein product due to the formation of an early stop codon.
Protein truncation APC protein corresponding to codons 1028-1700 was synthesised in vitro in a coupled transcription and translation reaction in order to detect protein-truncating mutations. A truncated peptide was detected in tumour GACA17 ( Figure  2 ). This gastric cancer showed the normal sized in vitro translation product of 67 kDa as well as a 44 kDa product. This shorter peptide corresponded in size to the mutant protein expected to be produced as a result of the deletion at codon 1462-1465 that we had previously detected by SSCP and heteroduplex analysis in this tumour, which thus served as a positive control. However, truncated proteins were not detected in the rest of our tumour series.
Restriction digest analysis for mutation detection PCR products digested with the appropriate restriction enzyme were analysed for specific chain-terminating mutations (Ando et al., 1993) (Figure 3 ). GACAl1   I  HOM  HET   GACA12   I  HET  HET  GACA13   I  HOM  HET  GACA14  I  HOM  HET   GACA15  I  HOM  LOH  GACA16  I  HOM  HET   GACA17   I  HET  HET  GACA18   D  HET  HET  GACA19  D  HOM  HET  GACA20  I   HET  HET   GACA21  I  HET  HET  GACA22  I  HET  HOM  GACA23  I  LOH  HOM  GACA24   D  HOM  HET  GACA25  I  HOM  HET  GACA26   I HET LOH aD, diffuse type; I, intestinal type. bHOM, homozygous; HET, constitutional heterozygosity retained; LOH, loss of heterozygosity.
We detected a somatic mutation of APC in only one of 26 (4%) gastric carcinomas. This was an intestinal-type tumour. Nakatsuru et al. (1992) identified APC gene mutations in 12 of 57 (21%) gastric cancers by RNAase protection analysis. These were differentiated carcinomas (intestinal-type according to classification of Lauren) and signet-ring cell carcinomas. However, no mutations were detected in 24 gastric carcinomas by Ogasawara et al. (1994) using SSCP analysis. In a larger study, these authors later found APC to be mutated in only one of 72 (1.4%) gastric cancers, a signetring cell carcinoma (Maesawa et al., 1995) . Considering these results it is probable that APC gene mutations do not occur in the majority of gastric cancers. They may be frequent only in certain histopathological types. APC mutations have been detected in 20-40% of gastric adenomas (Nakatsuru et al., 1993; Tamura et al., 1994) , which are thought to be precursors of some differentiated types of gastric cancer. Nakatsuru et al. (1992) divided differentiated-type carcinomas into 'very well-differentiated' and 'well-or moderately differentiated' types and found mutations were significantly more frequent in the very well-differentiated carcinoma.
We analysed the 5' half of exon 15 as did the above authors because the majority of mutations have been localised to this part of the gene and it includes a region where two-thirds of somatic mutations in colorectal tumours are clustered (MCR) . The mutation we identified was located at a particular hotspot in this region (codon 1462-1465) . A similar mutation at this position was identified in two flat adenomas of the stomach by Nakatsuru et al. (1993) . We screened four earlier exons in addition by SSCP and heteroduplex analysis and by restriction digest analysis for specific mutations, but failed to detect any mutants. It remains possible that mutations in gastric carcinomas are frequent in areas of the gene other than those that correspond to mutation cluster regions in colorectal carcinomas. We did observe LOH of APC in one gastric tumour (Table III) , which may have harboured a mutation in the other APC allele in accordance with Knudson's hypothesis (Knudson, 1971) .
We used a combination of mutation detection methods. Our SSCP and heteroduplex analysis was automated, which allowed optimal and precise control of electrophoretic conditions. We have previously found this assay to be efficient in the detection of germline mutations and polymorphic variants in FAP patients (Gayther et al., 1994 (Gayther et al., , 1995 . We employed the PTT as a secondary screening technique to detect chain-terminating mutations as the great majority of mutations in APC lead to truncation of the protein product . The combination of these techniques has led to the detection of causative APC germline mutations in 66% of families studied (Wells et al., unpublished observations) . Approximately half of the APC mutations detected in gastric carcinomas by Nakatsuru et al. (1992) using RNAase protection analysis were missense mutations. The sensitivity of SSCP for the detection of single base substitutions has been reported to be greatest for molecules shorter than 200 bp (Sheffield et al., 1993) . In our study PCR fragments for exon 15A-J, generated using primer sets described by Groden et al. (1991) , were larger in size (312-508 bp). It cannot be excluded that this led to a decreased sensitivity of base substitution and hence missense mutation detection. We have, however, found that seven of 17 somatic variants identified in 16 sporadic colorectal cancers in exon 1 5A-J using the same SSCP conditions as the present study, were the result of single base changes (Sud et al., unpublished data) . This is the first report on mutations of the APC gene in gastric cancers from Western patients. We think that APC mutations occur only in the minority of gastric cancers from both British and Japanese patients. We observed LOH of APC in only 8% of cases, and of MCC in 10% of cases. LOH of MCC occurred independently of APC in one case (Table III) . The incidence of LOH of chromosome 5q is higher in Japanese gastric cancers (87% of cases by Tamura et al., 1993; 42% of well-differentiated carcinomas by Sano et al., 1991) . It is possible that mutations in a tumoursuppressor gene(s) on chromosome 5q other than APC is responsible for the frequent LOH, as has been suggested for other solid tumours Powell et al., 1994) , possibly MCC. We do not think this would be a significant event in our tumours as the incidence of 5q-LOH (12.5% of cases) is very low. In a smaller study on gastric carcinomas from the UK, Fey et al. (1989) also described infrequent LOH on chromosome 5q (10% of cases). It therefore appears that some molecular differences may exist between British and Japanese gastric cancers.
We did not detect any alterations in diffuse-type cancers. This histological type usually contains a higher proportion of non-neoplastic stromal cells which can inhibit the detection of genetic alterations. In this study only tumour samples that contained mainly malignant cells (>50%) as determined by cryostat sectioning were used. However, alterations of APC and MCC were also infrequent in intestinal-type tumours. We conclude that tumour-suppressor genes on other chromosomes must play a more important role in the development of gastric cancer in patients from the British population.
